1. Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928

2. Predictors of death* Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928

3. Baseline characteristics Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928

4. Distribution of statin use by age category and duration of use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928

5. Adjusted* mean change and posttreatment mean lipid profiles with statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928

6. Age distribution at death among statin users and nonusers Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928 Note, age at death was 2.1 years older among statin users (mean, compared with nonusers, P<0.0001

7. Graded relation between risk of death and benefit of statin therapy Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928 For risk scores >1, reduction in death was highly significant (all p<0.0001). OR=odds ratio